Login / Signup

Androgen deprivation therapy in men with prostate cancer is not associated with COVID-2019 infection.

Sabina DavidssonAnna Messing ErikssonRuzan UdumyanPer SwanholmMaria Lewin LundhCarolina WidingChristina LindlöfJonna FridfeldtSven-Olof AnderssonKatja Fall
Published in: The Prostate (2023)
Our results do not support the hypothesis that ADT use in prostate cancer patients reduces the risk or symptom severity of SARS-CoV-2 infection or that prostate cancer patients are at increased risk of COVID-19 compared with men without prostate cancer.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • coronavirus disease
  • sars cov
  • middle aged
  • respiratory syndrome coronavirus
  • stem cells
  • mesenchymal stem cells
  • patient reported